Cheaper cancer drug copycat enters final testing phase
NCT ID NCT07162883
Summary
This study aims to see if a new drug called QL2107 behaves the same way in the body as the established cancer drug Keytruda. It will involve 122 adults with non-small cell lung cancer who have had their tumor surgically removed and completed chemotherapy. The main goal is to prove the two drugs have similar blood concentration levels, which is a key step in creating a more affordable alternative treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARCINOMA, NON-SMALL-CELL LUNG are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.